Foghorn Therapeutics Inc. (FHTX)

Foghorn Therapeutics Revenue

Foghorn Therapeutics had revenue of $5.95M in the quarter ending March 31, 2025, with 17.86% growth. This brings the company's revenue in the last twelve months to $23.50M, down -30.66% year-over-year. In the year 2024, Foghorn Therapeutics had annual revenue of $22.60M, down -33.83%.

• Revenue (ttm): $23.50M
• Revenue Growth: -30.66%
• P/S Ratio: 12.13
• Revenue / Employee: $209,857
• Employees: 112
• Market Cap: 269.79M

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	22.60M	-11.55M	-33.83%
Dec 31, 2023	34.16M	14.93M	77.63%
Dec 31, 2022	19.23M	17.91M	1,357.77%
Dec 31, 2021	1.32M	889.00K	206.74%
Dec 31, 2020	430.00K	-	-

Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.